KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Share-based Compensation (2016 - 2025)

Medpace Holdings' Share-based Compensation history spans 11 years, with the latest figure at $5.6 million for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 4.57% year-over-year to $5.6 million; the TTM value through Dec 2025 reached $34.8 million, up 36.34%, while the annual FY2025 figure was $34.8 million, 36.34% up from the prior year.
  • Share-based Compensation reached $5.6 million in Q4 2025 per MEDP's latest filing, down from $6.3 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $16.9 million in Q1 2025 to a low of $2.9 million in Q1 2021.
  • Average Share-based Compensation over 5 years is $5.8 million, with a median of $5.3 million recorded in 2023.
  • Peak YoY movement for Share-based Compensation: tumbled 47.27% in 2021, then surged 291.93% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $4.0 million in 2021, then skyrocketed by 40.49% to $5.6 million in 2022, then decreased by 7.65% to $5.2 million in 2023, then increased by 14.02% to $5.9 million in 2024, then decreased by 4.57% to $5.6 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Share-based Compensation are $5.6 million (Q4 2025), $6.3 million (Q3 2025), and $6.0 million (Q2 2025).